secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACTUATE THERAPEUTICS, INC. (ACTU)
CIK:        0001652935
Form:       8-K
Filed at:   2025-02-07T23:59:59+00:00
Accession:  0001683168-25-000826
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Actuate Therapeutics sets first annual meeting for May 22, 2025; deadlines announced
--------------------------------------------------------------------------------

- First Annual Meeting of Stockholders will be held virtually on May 22, 2025.
- Record date for voting entitlement is March 25, 2025.
- Rule 14a-8 stockholder proposals must be received by February 21, 2025, for proxy inclusion.
- Advance notice for director nominations and other proposals also due by February 21, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1652935/000168316825000826/0001683168-25-000826-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1652935/000168316825000826/actuate_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-000826

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer